Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Clinical Study1
- Comparative Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Chemotherapy1
Search Results
Sort by
- BookSeung-Kyu Han.Contents:
1. Basics of wound healing
2. Interactive wound dressings
3. Biologic dermis graft
4. Tissue-engineered dermis graft
5. Atypical island flaps
6. Management of chronic wounds: with focus on diabetic ulcers
7. Infection, debridement, and biofilm
8. Negative-pressure wound therapy
9. Growth factor therapy
10. Cell therapy
11. Adjunctive therapy
12. Injectable tissue-engineered soft tissue. - ArticlePines A, Nandi AR, Raafat H, Rahman M.Chemotherapy. 1977;23(1):58-64.100 hospital patients suffered from acute exacerbations of chronic bronchitis. 50 were treated with amoxycillin in a dose of 500 mg, three times a day for 10 days and the results compared with 50 patients treated with co-trimoxazole in a dose up to 480 mg trimethoprim and 2,400 mg of sulphamethoxazole daily in males, and two thirds of this dose in females. The trial was single-blind. During the acute phase of infection, both treatments were equally effective in clinical improvement, conversion of the sputum from purulent to mucoid, diminution of quantity and elimination of pathogenic bacteria. Amoxycillin was quicker in sputum conversion and gave less side effects, but the differences were not significant. During the 2-4 weeks following treatment, only a third of the patients who had received co-trimoxazole remained well and free from purulent relapse, as opposed to 72% who had received amoxycillin, a difference significant at the 2% level.